Compare PTRN & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTRN | PAHC |
|---|---|---|
| Founded | 2013 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.1B |
| IPO Year | N/A | 2014 |
| Metric | PTRN | PAHC |
|---|---|---|
| Price | $11.62 | $53.95 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 3 |
| Target Price | $19.56 | ★ $34.33 |
| AVG Volume (30 Days) | ★ 980.1K | 258.4K |
| Earning Date | 03-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.86% |
| EPS Growth | N/A | ★ 1883.33 |
| EPS | N/A | ★ 1.32 |
| Revenue | N/A | ★ $833,350,000.00 |
| Revenue This Year | $27.89 | $17.03 |
| Revenue Next Year | $22.19 | $3.82 |
| P/E Ratio | ★ N/A | $42.28 |
| Revenue Growth | N/A | ★ 4.12 |
| 52 Week Low | $9.19 | $16.16 |
| 52 Week High | $20.10 | $57.62 |
| Indicator | PTRN | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 50.47 | 55.44 |
| Support Level | $10.94 | $37.09 |
| Resistance Level | $12.60 | $56.14 |
| Average True Range (ATR) | 0.71 | 2.43 |
| MACD | 0.14 | 0.22 |
| Stochastic Oscillator | 42.68 | 57.90 |
Pattern Group Inc is an ecommerce accelerator, uses its technology platform, data science and a team of experts to drive growth for brands. The Company acquires inventory from brand partners to sell to consumers, enabling full control over content, pricing, logistics and customer service. Brand partners that contract with the Company operate in various industries including health and wellness, beauty and personal care, home and lifestyle, pet, sports and outdoors and consumer electronics.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.